Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Value of Drug–Drug Interaction Risk Assessments

Posted on June 28th, 2017 by in Pharma R&D

Should a drug candidate move on to pre-clinical and clinical trials? It’s a question that every pharmaceutical developer must face, and the earlier they can answer it, the better in terms of use of time and effort. Continue reading “The Value of Drug–Drug Interaction Risk Assessments” »

Start-up Spotlight: Innovative Informatica Technologies

Posted on November 4th, 2016 by in Pharma R&D

In our data-driven age, bioinformatics companies like Innovative Informatica Technologies have a great deal to offer the industry and boast the potential to do amazing things in drug discovery. Syed Hussain Basha, Founder & CEO of this ambitious start-up, reveals what the company is currently working on.

Continue reading “Start-up Spotlight: Innovative Informatica Technologies” »

Predictions, Modelling and Simulations: Their role in R&D decision-making is more “what” than “how”?

Posted on August 8th, 2016 by in Pharma R&D

R_D_Solutions_Blog_Data_Center_DIGITAL

“Predictions are difficult, especially when they are about the future”, a statement attributed to the Noble laurate Niels Bohr is very true.  Despite these difficulties, the Pharma industry has built a range of predictive models to understand a range of drug actions including toxicity, disposition, elimination and efficacy.  Continue reading “Predictions, Modelling and Simulations: Their role in R&D decision-making is more “what” than “how”?” »

When drugs collide ….

Posted on July 15th, 2016 by in Pharmacovigilance

Pharmaceutical companies increasingly are adopting “proactive pharmacovigilance” and other strategies to help ensure the safety of a new entity as early as possible in the discovery/development process. Continue reading “When drugs collide ….” »

  1. 1
  2. 2